Neuro-oncology is a specialized field of medicine that focuses on the prevention, diagnosis, treatment, and rehabilitation of individuals with primary central nervous system (CNS) tumors. The CNS includes the brain, nerves, and spinal cord. These tumors can affect people of any age, gender, or race. Although they are rare, the incidence of primary CNS tumors is increasing. Neuro-oncologists are medical specialists who take a multidisciplinary approach to treating these tumors. This means that they work in teams of neurologists, neurosurgeons, oncologists, radiation oncologists, radiologists, and pathologists to provide comprehensive care. Treatment of brain tumors depends on the type and stage of the tumor. Surgery is often the first step in treatment, followed by radiation therapy and/or chemotherapy. Many tumors are sensitive to chemotherapy drugs, but some require different types of treatment. Neuro-oncologists are also involved in clinical trials to evaluate new treatments and find new therapies that may be more effective. They work with patients to understand what type of treatment is suitable for their particular condition. The goal of neuro-oncology is to provide the patient with the best possible outcome and quality of life during and after treatment. Neuro-oncology specialists are dedicated to understanding the complexities of CNS tumors and finding cures for them.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom